news biocon: Billion dollar target for biologics biz by FY22 unrealistic, but we would soon return to high growth trajectory: Kiran Mazumdar Shaw April 29, 2021
news Biocon Q4 results: Biocon Q4 results: Net profit grows 105% on strong biosimilar business growth April 29, 2021
